GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Cannabis Sativa Inc (OTCPK:CBDS) » Definitions » Sloan Ratio %

Cannabistiva (Cannabistiva) Sloan Ratio % : 0.00% (As of Sep. 2023)


View and export this data going back to 2010. Start your Free Trial

What is Cannabistiva Sloan Ratio %?

Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.

Cannabistiva's Sloan Ratio for the quarter that ended in Sep. 2023 was 0.00%.

Warning Sign:

When sloan ratio (-32.44)% higher than 25% or lower than -25%, earnings are more likely to be made up of accruals.

As of Sep. 2023, Cannabistiva has a Sloan Ratio of 0.00%, indicating the company is in the safe zone and there is no funny business with accruals.


Cannabistiva Sloan Ratio % Historical Data

The historical data trend for Cannabistiva's Sloan Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cannabistiva Sloan Ratio % Chart

Cannabistiva Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Sloan Ratio %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -70.57 -133.43 -61.36 -86.81 -32.44

Cannabistiva Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Sloan Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Cannabistiva's Sloan Ratio %

For the Health Information Services subindustry, Cannabistiva's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cannabistiva's Sloan Ratio % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Cannabistiva's Sloan Ratio % distribution charts can be found below:

* The bar in red indicates where Cannabistiva's Sloan Ratio % falls into.



Cannabistiva Sloan Ratio % Calculation

Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.

Cannabistiva's Sloan Ratio for the fiscal year that ended in Dec. 2022 is calculated as

Sloan Ratio=(Net Income (A: Dec. 2022 )-Cash Flow from Operations (A: Dec. 2022 )
-Cash Flow from Investing (A: Dec. 2022 ))/Total Assets (A: Dec. 2022 )
=(-1.127--0.236
--0.057)/2.571
=-32.44%

Cannabistiva's Sloan Ratio for the quarter that ended in Sep. 2023 is calculated as

Sloan Ratio=(Net Income (TTM)-Cash Flow from Operations (TTM))
-Cash Flow from Investing (TTM))/Total Assets (Q: Sep. 2023 )
=(-1.701--0.147
--0.01)/2.123
=-72.73%

Cannabistiva's Net Income for the trailing twelve months (TTM) ended in Sep. 2023 was -0.618 (Dec. 2022 ) + -0.523 (Mar. 2023 ) + -0.332 (Jun. 2023 ) + -0.228 (Sep. 2023 ) = $-1.70 Mil.
Cannabistiva's Cash Flow from Operations for the trailing twelve months (TTM) ended in Sep. 2023 was -0.115 (Dec. 2022 ) + 0.004 (Mar. 2023 ) + -0.056 (Jun. 2023 ) + 0.02 (Sep. 2023 ) = $-0.15 Mil.
Cannabistiva's Cash Flow from Investing for the trailing twelve months (TTM) ended in Sep. 2023 was 0 (Dec. 2022 ) + -0.01 (Mar. 2023 ) + 0 (Jun. 2023 ) + 0 (Sep. 2023 ) = $-0.01 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cannabistiva  (OTCPK:CBDS) Sloan Ratio % Explanation

A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.

According to How to Beat the Market with the Sloan Ratio:

If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.

If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.

If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.

As of Sep. 2023, Cannabistiva has a Sloan Ratio of 0.00%, indicating the company is in the safe zone and there is no funny business with accruals.


Cannabistiva Sloan Ratio % Related Terms

Thank you for viewing the detailed overview of Cannabistiva's Sloan Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


Cannabistiva (Cannabistiva) Business Description

Traded in Other Exchanges
N/A
Address
450 Hillside Drive, Suite A224, Mesquite, NV, USA, 89027
Cannabis Sativa Inc along with its subsidiaries engages in the telemedicine business. It offers an online telemedicine platform providing customers access to knowledgeable physicians to obtain a medical marijuana recommendation.
Executives
Brad E Herr director, officer: Chief Financial Officer 5413 S SAYBROOK LANE, SPOKANE WA 99223
David Tobias director, 10 percent owner PO BOX 1602, MESQUITE NV 89024
Tankson Robert N. Iii director 6057 RYAN RANCH AVE, LAS VEGAS NV 89130
Donald Lundbom officer: CHIEF FINANCIAL OFFICER 37177 N WILD BARLEY PATH, SAN TAN VALLEY AZ 85140
Sadia P Barrameda 10 percent owner PO BOX 1363, DISCOVERY BAY CA 94505
Mike Gravel director 4467 OCEAN HEIGHTS CT,, SEASIDE CA 93955
Stephen Michael Downing director 152 LA VERNE AVENUE, LONG BEACH CA 90803
Debby Goldsberry director 1707 LEIMERT BLVD, OAKLAND CA 94607
Trevor S Reed director 20 BRAZOS TRAIL COURT, PLACITAS NM 87043
Catherine J Carroll director, officer: CFO and Treasurer 450 HILLSIDE DRIVE A224, MESQUITE NV 89027
James Polin Gray director 2531 CRESTVIEW DRIVE, NEWPORT BEACH CA 92663
Gary Earl Johnson director, officer: President, CEO & Secretary P.O. BOX 1858, EL PRADO NM 87529
Steve Kubby director, 10 percent owner, officer: Chairman of the Board 317 JUDITH'S FANCY, ST. CROIX VI 00823-5335
Barry Robert Tobias director 7305 DAMSEL LANE, FAIRVIEW TN 37062
Kirk Blosch 10 percent owner 2081 SOUTH LAKELINE DR, SALT LAKE CITY UT 84109